Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Provention Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Provention Bio, Inc. PRVB | Venrock Healthcare Capital Partners II L.P. | 1,118,653 1.300% | -2,725,143 (-70.90%) | Filing |
| 2021-06-07 4:30 pm Purchase | 2021-05-26 | 13G | Provention Bio, Inc. PRVB | Venrock Healthcare Capital Partners II L.P. | 3,843,796 6.100% | 3,843,796 (New Position) | Filing |